Loading clinical trials...

COMPLETEDNA

An Integrated Substance Abuse-Domestic Violence (SADV) Treatment Outcome Study

An Integrated Substance Abuse-Domestic Violence (SADV) Treatment Outcome Study: A Stage 1 Trial for SADV

NCT07140276•Yale University

Summary

Investigators will conduct a randomized trial comparing individual SADV to a manualized comparison condition that focuses on substance use only.

Detailed Description

The randomized trial will be informed by previous work developing and refining the interventions and training materials used in the randomized trial. The focus of this registration is the randomized trial.

Eligibility

Age

18 - No limit years

Sex

MALE

Healthy Volunteers

Inclusion Criteria

•referred by the courts or probation for treatment of substance use and domestic violence and who
•meet current DSM-IV criteria for substance dependence (alcohol, cocaine and marijuana, and who have used that substance within the 30 days prior to the screening session)
•report physical violence in an intimate relationship (pushing, slapping, kicking) within 30 days prior to screening
•can read English at a 6th grade level.

Exclusion Criteria

•Currently in withdrawal from substances and in need of detoxification (such individuals may be re-evaluated following detoxification)
•Have cognitive impairment (a mini mental state score \<25)
•Have psychomotor epilepsy (e.g. impulsivity or rage related symptoms secondary to a seizure disorder, as this medical diagnosis is likely to be a confound in the proposed study)
•Have major medical complications such as a head injury/trauma, or HIV dementia that may also be a confound in the study interventions
•Currently receiving either substance abuse or IPV treatment elsewhere
•Have a lifetime history of any psychotic or bipolar disorder
•Currently suicidal or homicidal.

Locations (1)

Yale New Haven Health System

New Haven, Connecticut, United States

Key Dates

Start Date

July 3, 2007

Primary Completion Date

June 30, 2010

Completion Date

June 30, 2010

Last Updated

August 24, 2025

Enrollment

ACTUAL participants

Conditions

Substance AbuseDomestic Violence

Interventions

Individual Therapy

BEHAVIORAL

Individual Drug Counseling manual

BEHAVIORAL

LIFUS For Neurological Disorders

NCT07417280

Parkinson's Disease (PD)Essential Tremor+5 more

View study

RECRUITINGNA

Occupational Therapy for Adults Who Have Experienced Intimate Partner Violence (IPV)

NCT06808828

Domestic Violence

View study

RECRUITINGNA

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 24, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

An Integrated Substance Abuse-Domestic Violence (SADV) Treatment Outcome Study

Inclusion Criteria

Exclusion Criteria

LIFUS For Neurological Disorders

Occupational Therapy for Adults Who Have Experienced Intimate Partner Violence (IPV)

Functional Connectivity Alterations in Suicidal Patients Among Opioid Users

Adaptation and Pilot Testing of Web and Mobile Interface for the ATTACH™ Intervention

Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention

Peer Counselling to Reduce Psychological Distress and Exposure to Violence Among Sexual and Gender Minorities